fda glp-1 compounding crackdown october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounders Argue US FDA's GLP-1

Boosting NAD(+) with a small molecule that activates NAMPT [PMID: 31324777] Laboratory literature summary: Boosting NAD(+) with a small molecule that activates NAMPT

Over three quarters of teenage asthma subjects also suffer from rhinitis (136)

Few studies were conducted to evaluate AOX therapy in women with endometriosis-associated infertility (168, 169)

You can read the abstract of this article at In a Phase 3 trial involving 1879 individuals with type 2 diabetes (T2D) on metformin, Tirzepatide (TZP) at doses of 5 and 15 mg demonstrated substantial improvements in HbA1c and weight reduction compared to 1 mg of semaglutide (SEMA)